Serrumab: a novel human single chain-fragment antibody with multiple scorpion toxin-neutralizing capacities (2013)
- Authors:
- USP affiliated authors: BRAGA, ELIANE CANDIANI ARANTES - FCFRP ; BARBOSA, JOSE ELPIDIO - FMRP
- Unidades: FCFRP; FMRP
- DOI: 10.3109/1547691X.2013.809175
- Subjects: VENENOS DE ORIGEM ANIMAL; ESCORPIÕES; ANTICORPOS MONOCLONAIS
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Immunotoxicology
- ISSN: 1547-691X
- Volume/Número/Paginação/Ano: on-line, 2013
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
PUCCA, Manuela Berto et al. Serrumab: a novel human single chain-fragment antibody with multiple scorpion toxin-neutralizing capacities. Journal of Immunotoxicology, 2013Tradução . . Disponível em: https://doi.org/10.3109/1547691X.2013.809175. Acesso em: 10 out. 2024. -
APA
Pucca, M. B., Cerni, F. A., Peigneur, S., Arantes, E. C., Tytgat, J., & Barbosa, J. E. (2013). Serrumab: a novel human single chain-fragment antibody with multiple scorpion toxin-neutralizing capacities. Journal of Immunotoxicology. doi:10.3109/1547691X.2013.809175 -
NLM
Pucca MB, Cerni FA, Peigneur S, Arantes EC, Tytgat J, Barbosa JE. Serrumab: a novel human single chain-fragment antibody with multiple scorpion toxin-neutralizing capacities [Internet]. Journal of Immunotoxicology. 2013 ;[citado 2024 out. 10 ] Available from: https://doi.org/10.3109/1547691X.2013.809175 -
Vancouver
Pucca MB, Cerni FA, Peigneur S, Arantes EC, Tytgat J, Barbosa JE. Serrumab: a novel human single chain-fragment antibody with multiple scorpion toxin-neutralizing capacities [Internet]. Journal of Immunotoxicology. 2013 ;[citado 2024 out. 10 ] Available from: https://doi.org/10.3109/1547691X.2013.809175 - Serrumab's multiple neutralizing capacities to scorpion toxins
- Serrumab: a human monoclonal antibody that counters the biochemical and immunological effects of Tityus serrulatus venon
- Human antibody fragments (scFv 2A) inhibit biochemical and immunological effects of Tityus serrulatus venon
- A human antibody fragment specific to Tityus serrulatus Ts1 major toxin recognizes other potential sodium channel toxins and could be used as a new ativenom
- Human antibody fragments inhibit the action of TsTx-I toxin in vitro and the lethality of the Tityus serrulatus venom in vivo
- Human antibody fragments (scFv) produced by phage display technology recognize Tityus serrulatus venom and inhibit the action of TsTx-1 toxin on 'Na POT.+' channels
- Anti-peptide antibody detecting a neo-antigen on the cri stump left on erythrocytes after proteolysis
- Expressão do receptor para complemento tipo 1(CR1) em eritrócitos de pacientes com leishmaniose visceral
- Complement receptor type 1 (CRI) expression on erythrocytes of patients with kala-azar
- Phage display as a novel promising antivenom therapy: a review
Informações sobre o DOI: 10.3109/1547691X.2013.809175 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
